Canada Pension Plan Investment Board
STOK icon

Canada Pension Plan Investment Board’s Stoke Therapeutics STOK Stock Holding History

Canada Pension Plan Investment Board’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$853K Sell
26,200
-9,000
-26% -$295K ﹤0.01% 1052
2025
Q4 		$1.12M Buy
+35,200
New +$1.06M ﹤0.01% 1044

Other funds holding STOK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Canada Pension Plan Investment Board's STOK Position: Q1 2026 in Review

Canada Pension Plan Investment Board reduced its Stoke Therapeutics (STOK) stake by 26% in Q1 2026, selling an estimated $295K and leaving 26,200 shares worth $853K. The position accounts for ﹤0.01% of the portfolio, ranked #1052.

Canada Pension Plan Investment Board first reported a position in STOK in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.12M in Q4 2025. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

  • Canada Pension Plan Investment Board held 26,200 shares of Stoke Therapeutics worth $853K as of Q1 2026.
  • Canada Pension Plan Investment Board sold 9,000 Stoke Therapeutics shares in Q1 2026, an estimated $295K.
  • Stoke Therapeutics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #1052 holding.
  • Canada Pension Plan Investment Board first reported a position in Stoke Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Canada Pension Plan Investment Board's Stoke Therapeutics position peaked at $1.12M in Q4 2025.
  • 196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.